Variant report
Variant | esv3467721 |
---|---|
Chromosome Location | chr4:165862102-165867000 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr4:165864460-165864610 | NHEK | skin: | n/a | n/a |
2 | CTCF | chr4:165864520-165864670 | MCF-7 | breast: | n/a | n/a |
3 | CTCF | chr4:165864593-165864638 | MCF-7 | breast: | n/a | n/a |
4 | CTCF | chr4:165864559-165864620 | MCF-7 | breast: | n/a | n/a |
5 | STAT3 | chr4:165866541-165866563 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | WRNIP1 | chr4:165864527-165864679 | GM12878 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:165866322..165867965-chr4:165877072..165879577,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236941 | TF binding region |
ENSG00000248645 | TF binding region |
NACA3P | TF binding region |
ENSG00000250486 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570478553 | chr4:165862149-165862150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376204026 | chr4:165862173-165862174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551421051 | chr4:165862250-165862251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138764859 | chr4:165862251-165862252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533980985 | chr4:165862308-165862309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181213312 | chr4:165862377-165862378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567283544 | chr4:165862378-165862379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537954989 | chr4:165862383-165862384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556590782 | chr4:165862408-165862409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367753012 | chr4:165862425-165862426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539204633 | chr4:165862447-165862448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554193888 | chr4:165862454-165862455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572772843 | chr4:165862463-165862464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570166875 | chr4:165862470-165862471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140367773 | chr4:165862524-165862525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561674958 | chr4:165862540-165862541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573631787 | chr4:165862542-165862543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543988685 | chr4:165862577-165862578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562590326 | chr4:165862578-165862579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4383571 | chr4:165862591-165862592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533008259 | chr4:165862659-165862660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185356399 | chr4:165862688-165862689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560231551 | chr4:165862699-165862700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7694572 | chr4:165862707-165862708 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs137936141 | chr4:165862718-165862719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567347246 | chr4:165862719-165862720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372463575 | chr4:165862732-165862733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537812445 | chr4:165862751-165862752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189846899 | chr4:165862757-165862758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367925675 | chr4:165862760-165862761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149454134 | chr4:165862772-165862773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370261568 | chr4:165862805-165862806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375392950 | chr4:165862845-165862846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554333835 | chr4:165862853-165862854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182127017 | chr4:165862939-165862940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187661340 | chr4:165862993-165862994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200918518 | chr4:165863040-165863041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs60635034 | chr4:165863041-165863042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200591986 | chr4:165863054-165863055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs58111719 | chr4:165863060-165863061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573715408 | chr4:165863084-165863085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544173205 | chr4:165863085-165863086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369563218 | chr4:165863103-165863104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12501482 | chr4:165863110-165863111 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs577660073 | chr4:165863227-165863228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs56921121 | chr4:165863265-165863266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544739944 | chr4:165863271-165863272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138722613 | chr4:165863288-165863289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80222343 | chr4:165863340-165863341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368544261 | chr4:165863341-165863342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:165859200-165864400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr4:165859200-165869200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:165864200-165864600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr4:165864200-165864800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr4:165864400-165864600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr4:165864400-165864600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
7 | chr4:165864400-165864800 | Enhancers | NHEK | skin |
8 | chr4:165864600-165864800 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr4:165864600-165865000 | Enhancers | HSMMtube | muscle |
10 | chr4:165864600-165865200 | Enhancers | Placenta Amnion | Placenta Amnion |
11 | chr4:165864600-165869200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr4:165864800-165869000 | Weak transcription | Fetal Muscle Leg | muscle |
13 | chr4:165864800-165869200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr4:165865800-165867000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:165866200-165866600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr4:165866200-165866800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr4:165866200-165866800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr4:165866600-165866800 | Enhancers | HMEC | breast |
19 | chr4:165866600-165868400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
20 | chr4:165866800-165869200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
21 | chr4:165866800-165870800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
22 | chr4:165867000-165870800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |